Earnings Feed
Start Free
Home/Insiders/RUBIN PAUL D
RP
SEC Insider//CIK 0001210905

RUBIN PAUL D

CIK 00012109054 companiesEMERYVILLE, CA
SEC Profile

Transactions

50

Companies

4

Filings

6

CIK

0001210905

Recent Transactions

50 trades
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-03-02$6.57/sh+2,000→ 7,433 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-03-02−2,000→ 3,383 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-03-02−5,433→ 5,437 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-03-02$4.11/sh+5,433→ 5,433 total
  • Sale
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-03-02$20.30/sh−7,433→ 0 total
  • Award
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-02-17+110,000→ 110,000 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-02-02$6.57/sh+2,000→ 7,433 total
  • Sale
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-02-02$18.75/sh−7,433→ 0 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-02-02−2,000→ 5,383 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-02-02−5,433→ 10,870 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-02-02$4.11/sh+5,433→ 5,433 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-01-02−5,433→ 16,303 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2026-01-02−2,000→ 7,383 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-01-02$4.11/sh+5,433→ 5,433 total
  • Sale
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-01-02$12.85/sh−7,433→ 0 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2026-01-02$6.57/sh+2,000→ 7,433 total
  • Sale
    BioAge Labs, Inc.$BIOA

    Common Stock

    2025-12-09$12.00/sh−18,000→ 0 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2025-12-09$6.57/sh+18,000→ 18,000 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2025-12-09−18,000→ 9,383 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2025-12-04−68,897→ 21,736 total
  • Exercise/Conversion
    BioAge Labs, Inc.$BIOA

    Common Stock

    2025-12-04$4.11/sh+68,897→ 68,897 total
  • Sale
    BioAge Labs, Inc.$BIOA

    Common Stock

    2025-12-04$10.19/sh−68,897→ 0 total
  • Award
    BioAge Labs, Inc.$BIOA

    Stock Option (Right to Buy)

    2025-02-18+200,000→ 200,000 total
  • Award
    Viridian Therapeutics, Inc.\DE$VRDN

    Stock Option (right to buy)

    2019-02-06+87,000→ 87,000 total
  • Award
    Viridian Therapeutics, Inc.\DE$VRDN

    Stock Option (right to buy)

    2018-01-31+85,000→ 85,000 total
  • Award
    Viridian Therapeutics, Inc.\DE$VRDN

    Stock Option (right to buy)

    2017-02-16+87,500→ 87,500 total
  • Sale
    XOMA Royalty Corp$XOMA

    Common Shares

    2016-03-22$0.78/sh−24,194→ 326,601 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Restricted Stock Units

    2016-03-18−12,141→ 0 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Common Shares

    2016-03-18+12,141→ 350,795 total
  • Award
    XOMA Royalty Corp$XOMA

    Common Shares

    2016-02-25+198,330→ 338,654 total
  • Other
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-12-31$1.38/sh+6,541→ 13,422 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-08-14+26,748→ 149,093 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Restricted Stock Units

    2015-08-14−26,748→ 0 total
  • Disposition to Issuer
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-08-14$0.83/sh−10,801→ 138,292 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Incentive Share Option (right to buy)

    2015-07-15$3.04/sh−5,000→ 27,040 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-07-15$3.04/sh+5,000→ 127,345 total
  • Sale
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-07-15$4.60/sh−5,000→ 122,345 total
  • Sale
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-07-10$4.55/sh−29,000→ 122,345 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Incentive Share Option (right to buy)

    2015-07-10$3.04/sh−29,000→ 32,040 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-07-10$3.04/sh+29,000→ 151,345 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-07-09$3.04/sh+4,400→ 126,745 total
  • Sale
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-07-09$4.55/sh−4,400→ 122,345 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Incentive Share Option (right to buy)

    2015-07-09$3.04/sh−4,400→ 61,040 total
  • Other
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-06-30$3.69/sh+575→ 124,377 total
  • Sale
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-05-28$3.60/sh−1,788→ 122,345 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Restricted Stock Units

    2015-05-28−4,666→ 0 total
  • Exercise/Conversion
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-05-28+4,666→ 124,133 total
  • Other
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-03-31$3.46/sh+1,457→ 120,924 total
  • Sale
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-03-23$3.94/sh−32,742→ 119,467 total
  • Disposition to Issuer
    XOMA Royalty Corp$XOMA

    Common Shares

    2015-03-18$4.01/sh−8,838→ 163,906 total

Companies

4

Recent Filings

6

Address

C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370

EMERYVILLE, CA, 94608

View on SEC.gov